Although the detailed mechanism of protection has yet to be fully understood, the successful action exerted by the Ndi1 protein in the animal model that closely mimics the pathophysiology of the disease is one critical step forward toward the goal of retarding PD by a novel strategy. This evidence concerns the gene AVPR2 and Parkinson disease.